ILA — Island Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00- AU$6.03m
- AU$5.56m
- AU$0.01m
Annual balance sheet for Island Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0 | 6.46 | 4.79 | 2 |
| Net Total Receivables | 0 | 0.059 | 0.021 | 0.017 |
| Prepaid Expenses | ||||
| Total Current Assets | 0 | 6.64 | 4.9 | 2.05 |
| Total Assets | 0 | 6.64 | 4.9 | 2.05 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.001 | 0.237 | 0.581 | 0.264 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.001 | 0.237 | 0.581 | 0.264 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | -0.001 | 6.4 | 4.32 | 1.79 |
| Total Liabilities & Shareholders' Equity | 0 | 6.64 | 4.9 | 2.05 |
| Total Common Shares Outstanding |